Andrey Boldyrev
Keine laufenden Positionen mehr
Profil
Mr. Andrey Boldyrev is Chief Executive Officer at MetaMax LLC.
Ehemalige bekannte Positionen von Andrey Boldyrev
| Unternehmen | Position | Ende |
|---|---|---|
MetaMax LLC
 MetaMax LLC Pharmaceuticals: MajorHealth Technology MetaMax LLC engages in the development and marketing of biopharmaceutical drugs. Its products include MM-D37K and chimeric peptide. Its technology is based on the use cell penetrating peptides for intracellular delivery of target antitumor peptides. The company was founded in 2010 and is located in Moscow, Russia. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
MetaMax LLC
MetaMax LLC Pharmaceuticals: MajorHealth Technology MetaMax LLC engages in the development and marketing of biopharmaceutical drugs. Its products include MM-D37K and chimeric peptide. Its technology is based on the use cell penetrating peptides for intracellular delivery of target antitumor peptides. The company was founded in 2010 and is located in Moscow, Russia. | Health Technology |
